Skip to main content
PLRX logo

PLRX

Pliant Therapeutics, Inc.
$1.11 -0.01 (-0.89%) At close · Jul 16
Market Cap
$71.21M
Shares
61,920,249

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Bernard Coulie $5,462,901
Keith Cummings $2,397,337
Minnie Kuo $1,542,854
Fiscal 2024
Executive Total
Bernard Coulie $6,614,704
Keith Cummings $3,099,874
Hans Hull $2,015,324
Mike Ouimette $1,994,260
Fiscal 2023
Executive Total
Bernard Coulie $11,165,999
Keith Cummings $4,438,908
Hans Hull $4,357,277
Mike Ouimette $3,316,978
Fiscal 2022
Executive Total
Bernard Coulie $10,927,715
Keith Cummings $3,443,354
Hans Hull $3,154,751
Mike Ouimette $2,542,248
Fiscal 2021
Executive Total
Bernard Coulie $5,221,353
Keith Cummings $1,883,743
Hans Hull $1,653,630
Barbara Howes $995,913
Mike Ouimette $805,039
Fiscal 2020
Executive Total
Bernard Coulie $2,391,822
Hans Hull $839,867
Fiscal 2019
Executive Total
Bernard Coulie $2,372,486
Hans Hull $846,266

Executive changes

Person Change Filed
Flavia Borellini, Ph.D. Appointed 2026-07-13
Robert Iannone, M.D., M.S.C.E. Appointed 2026-07-13
Key facts CIK 1746473 CUSIP 729139105 13F (30d) 3 filings 3 filers Visit website Investor relations